MARC record from Internet Archive

LEADER: 04080cam 2200841 a 4500
001 ocm36824876
003 OCoLC
005 20200519052416.0
008 970424s1997 nyua b 001 0 eng
010 $a 97019503
040 $aDLC$beng$cDLC$dNLM$dBAKER$dBTCTA$dYDXCP$dBTN$dBDX$dOCLCO$dOCLCF$dOCLCQ$dOCLCO$dOCLCQ$dOCLCO$dOCLCQ$dOCLCO$dTHHCU$dVGM$dTHHCU$dWURST$dSFB$dOCLCA
016 7 $a9717502$2DNLM
020 $a0789001233$q(alk. paper)
020 $a9780789001238$q(alk. paper)
020 $a0789004143$q(pbk. ;$qalk. paper)
020 $a9780789004147$q(pbk. ;$qalk. paper)
035 $a(OCoLC)36824876
050 00 $aRS160$b.A78 1997
060 00 $a1997 K-938
060 10 $aQV 752$bA792d 1997
082 00 $a615/.19$221
100 1 $aArtuso, Anthony.
245 10 $aDrugs of natural origin :$beconomic and policy aspects of discovery, development, and marketing /$cAnthony Artuso.
260 $aNew York :$bPharmaceutical Products Press,$c℗♭1997.
300 $a201 pages :$billustrations ;$c22 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages 183-191) and index.
520 1 $a"Drugs of Natural Origin gives you a detailed model of the value of wild biological resources for pharmaceutical research and development. Author Anthony Artuso presents several decision models and analytical techniques that you can use to asses the economics of biochemical prospecting efforts whether you're part of a private corporation, nonprofit research institute, developing country government, or international organization."--Jacket.
505 0 $aCh. 1. Biodiversity and the Search for New Drugs -- Ch. 2. A Model of the Biochemical Prospecting Process -- Ch. 3. Host Country Options for Conservation and Sustainable Development -- Ch. 4. Contractual Arrangements for Allocating Risks and Rewards -- Ch. 5. International Policy Implications -- App. A. Simulated Distribution of Returns from Biochemical Prospecting Opportunity -- App. B. Two-Period, Two-Site, Dynamic Programming Land-Use Planning.
650 0 $aPharmacognosy$xGovernment policy.
650 0 $aPharmacognosy$xEconomic aspects.
650 0 $aBiodiversity conservation$xEconomic aspects.
650 0 $aBiodiversity conservation$xGovernment policy.
650 0 $aPharmaceutical policy.
650 12 $aPharmacognosy.
650 22 $aPublic Policy.
650 22 $aConservation of Natural Resources.
650 22 $aEcosystem.
650 7 $aBiodiversity conservation$xEconomic aspects.$2fast$0(OCoLC)fst01429866
650 7 $aBiodiversity conservation$xGovernment policy.$2fast$0(OCoLC)fst01429872
650 7 $aPharmaceutical policy.$2fast$0(OCoLC)fst01060194
650 7 $aPharmacognosy$xEconomic aspects.$2fast$0(OCoLC)fst01060247
650 7 $aPharmacognosy$xGovernment policy.$2fast$0(OCoLC)fst01060248
653 00 $afarmacologie
653 00 $apharmacology
653 00 $amedicinale planten
653 00 $amedicinal plants
653 00 $ageneesmiddelen
653 00 $adrugs
653 00 $asoortendiversiteit
653 00 $aspecies diversity
653 00 $agenetische bronnen
653 00 $agenetic resources
653 10 $aMedicinal Crops
653 20 $aPharmacology
653 10 $aMedicinale planten
653 20 $aFarmacologie
776 08 $iOnline version:$aArtuso, Anthony.$tDrugs of natural origin.$dNew York : Pharmaceutical Products Press, ℗♭1997$w(OCoLC)645877038
938 $aBaker & Taylor$bBKTY$c140.00$d140.00$i0789001233$n0003006576$sactive
938 $aBaker & Taylor$bBKTY$c39.95$d39.95$i0789004143$n0003006577$sactive
938 $aBrodart$bBROD$n53715926$c$39.95
938 $aBaker and Taylor$bBTCP$n97019503
938 $aYBP Library Services$bYANK$n1406508
029 1 $aAU@$b000013186649
029 1 $aNLGGC$b174212887
029 1 $aNLM$b9717502
029 1 $aNZ1$b4310227
029 1 $aYDXCP$b1406501
029 1 $aYDXCP$b1406508
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 151 OTHER HOLDINGS